The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously publis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Piotr Alster, Anna Dunalska, Bartosz Migda, Natalia Madetko, Leszek Królicki
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
PSP
CBS
Acceso en línea:https://doaj.org/article/5ce6cd58e55642fabacee8cab9316299
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ce6cd58e55642fabacee8cab9316299
record_format dspace
spelling oai:doaj.org-article:5ce6cd58e55642fabacee8cab93162992021-11-08T07:48:25ZThe Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study1664-229510.3389/fneur.2021.767480https://doaj.org/article/5ce6cd58e55642fabacee8cab93162992021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.767480/fullhttps://doaj.org/toc/1664-2295Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously published research has confirmed risk factors that may impact the course of PSP and CBS, among them hypertension and diabetes. Less data is available regarding prediabetes and glycemic variability. In this study, 26 patients with clinical diagnoses of PSP and CBS were examined using glycated hemoglobin and perfusion single-photon emission tomography (SPECT). Patients were divided into two groups—PSP/CBS patients with glycated hemoglobin (HbA1c) below and above 5.7%. The results of the perfusion evaluation were compared with the values from healthy volunteers from the software's database. A decrease in perfusion in certain regions of interest was observed among patients affected by increased glycemic variability. A more pronounced decrement in perfusion was observed only in some regions of interest—the hippocampus, pons, left thalamus, right insula. The results indicated that, among PSP/CBS patients, individuals with more pronounced glycemic variability had more severe hypoperfusion in certain brain regions in comparison with PSP/CBS patients without carbohydrate metabolism disorders. Due to the fact that PSP and CBS are associated with cognitive impairment, an additional decrease in perfusion in the hippocampal area may impact the rate of cognitive deterioration.Piotr AlsterAnna DunalskaBartosz MigdaNatalia MadetkoLeszek KrólickiFrontiers Media S.A.articlePSPCBSSPECTprediabetesperfusionNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic PSP
CBS
SPECT
prediabetes
perfusion
Neurology. Diseases of the nervous system
RC346-429
spellingShingle PSP
CBS
SPECT
prediabetes
perfusion
Neurology. Diseases of the nervous system
RC346-429
Piotr Alster
Anna Dunalska
Bartosz Migda
Natalia Madetko
Leszek Królicki
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
description Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously published research has confirmed risk factors that may impact the course of PSP and CBS, among them hypertension and diabetes. Less data is available regarding prediabetes and glycemic variability. In this study, 26 patients with clinical diagnoses of PSP and CBS were examined using glycated hemoglobin and perfusion single-photon emission tomography (SPECT). Patients were divided into two groups—PSP/CBS patients with glycated hemoglobin (HbA1c) below and above 5.7%. The results of the perfusion evaluation were compared with the values from healthy volunteers from the software's database. A decrease in perfusion in certain regions of interest was observed among patients affected by increased glycemic variability. A more pronounced decrement in perfusion was observed only in some regions of interest—the hippocampus, pons, left thalamus, right insula. The results indicated that, among PSP/CBS patients, individuals with more pronounced glycemic variability had more severe hypoperfusion in certain brain regions in comparison with PSP/CBS patients without carbohydrate metabolism disorders. Due to the fact that PSP and CBS are associated with cognitive impairment, an additional decrease in perfusion in the hippocampal area may impact the rate of cognitive deterioration.
format article
author Piotr Alster
Anna Dunalska
Bartosz Migda
Natalia Madetko
Leszek Królicki
author_facet Piotr Alster
Anna Dunalska
Bartosz Migda
Natalia Madetko
Leszek Królicki
author_sort Piotr Alster
title The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
title_short The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
title_full The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
title_fullStr The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
title_full_unstemmed The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
title_sort rate of decrease in brain perfusion in progressive supranuclear palsy and corticobasal syndrome may be impacted by glycemic variability—a pilot study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5ce6cd58e55642fabacee8cab9316299
work_keys_str_mv AT piotralster therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT annadunalska therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT bartoszmigda therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT nataliamadetko therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT leszekkrolicki therateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT piotralster rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT annadunalska rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT bartoszmigda rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT nataliamadetko rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
AT leszekkrolicki rateofdecreaseinbrainperfusioninprogressivesupranuclearpalsyandcorticobasalsyndromemaybeimpactedbyglycemicvariabilityapilotstudy
_version_ 1718442812310028288